LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Kaerus Bioscience (www.kaerusbio.com), a clinical-stage biopharmaceutical company created by Medicxi for the development…
NEW YORK, March 6, 2025 /PRNewswire/ -- Baruch College ("Baruch"), a public college in New York City, is providing notice of…
Nashville, TN-based NonProfit Focused on Improving Systems Through Safety Science and Evidence-Based Approaches NASHVILLE, Tenn., March 6, 2025 /PRNewswire/ -- The…
Two Presentations Highlight Data Demonstrating Hypericin Photodynamic Therapy Potential with a Preliminary Comparison to Current Therapy PRINCETON, N.J., March 6,…
WELLESLEY, Mass., March 5, 2025 /PRNewswire/ -- Sun Life U.S., a leading provider of employee benefits and human resource technology solutions,…
She will replace President and CEO Marian Baldini who will be retiring in December BLUE BELL, Pa., March 3, 2025…
Nes-Ziona, Israel, March 03, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy…
NKGen explores the use of troculeucel as a potential treatment option for post-stroke patients.SANTA ANA, Calif., March 03, 2025 (GLOBE…
BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights…
NEW ROCHELLE, N.Y., Feb. 27, 2025 /PRNewswire/ -- A new article in Autism and Adulthood presents guidelines for designing consent materials…